J&J Medical Connect
CAPLYTA®

(lumateperone)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

CAPLYTA® (lumateperone)
Medical Information

CAPLYTA - Use in Patients with Parkinson’s Disease

Last Updated: 03/18/2026

SUMMARY  

  • CAPLYTA is not indicated for use in patients with Parkinson’s disease.
  • Clinical studies designed to evaluate the efficacy and/or safety of CAPLYTA in patients with Parkinson’s disease have not been performed.  

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT® (and/or other resources, including internal/external databases) conducted on 13 October 2025 did not identify any relevant citations pertaining to this topic.

Would you like to clear and leave your conversation? Message history will be lost.